Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Home
Business
Business Home
Economy
Technology
Media
Small Business
Legal
Deals
Earnings
Social Pulse
Business Video
The Freeland File
Markets
Markets Home
U.S. Markets
European Markets
Asian Markets
Global Market Data
Indices
M&A
Stocks
Bonds
Currencies
Commodities
Futures
Funds
peHUB
World
World Home
U.S.
Brazil
China
Euro Zone
Japan
Mexico
Russia
India Insight
World Video
Reuters Investigates
Decoder
Politics
Politics Home
Election 2012
Campaign Polling
Tales from the Trail
Political Punchlines
Supreme Court
Politics Video
Tech
Technology Home
MediaFile
Science
Tech Video
Tech Tonic
Social Pulse
Opinion
Opinion Home
Chrystia Freeland
John Lloyd
Felix Salmon
Jack Shafer
David Rohde
Bernd Debusmann
Nader Mousavizadeh
Lucy P. Marcus
David Cay Johnston
Bethany McLean
Anatole Kaletsky
Edward Hadas
Hugo Dixon
Ian Bremmer
Lawrence Summers
Susan Glasser
The Great Debate
Steven Brill
Jack & Suzy Welch
Frederick Kempe
Christopher Papagianis
Mark Leonard
Breakingviews
Equities
Credit
Private Equity
M&A
Macro & Markets
Politics
Breakingviews Video
Money
Money Home
Tax Break
Lipper Awards 2012
Global Investing
MuniLand
Unstructured Finance
Linda Stern
Mark Miller
John Wasik
James Saft
Analyst Research
Alerts
Watchlist
Portfolio
Stock Screener
Fund Screener
Personal Finance Video
Money Clip
Investing 201
Life
Health
Sports
Arts
Faithworld
Business Traveler
Entertainment
Oddly Enough
Lifestyle Video
Pictures
Pictures Home
Reuters Photographers
Full Focus
Video
Reuters TV
Reuters News
Article
Comments (0)
Slideshow
Follow Reuters
Facebook
Twitter
RSS
YouTube
Read
Turkish PM warns Syria of backlash
|
12:39pm EDT
Insight: A land owner caught between energy giants
7:05am EDT
Raging Colorado wildfire grows near US Air Force Academy
|
25 Jun 2012
One dead, 2 hurt in natgas blast in Colorado-media
10:44am EDT
Wall Street flat on euro zone worries, weak consumer sentiment
|
11:48am EDT
Discussed
129
Obama campaign requests outside Republican group disclose donors
119
House panel to vote on Holder contempt charge: aide
92
California tobacco tax hike narrowly defeated at polls
Watched
Brit promotes online French chic
Mon, Jun 25 2012
Finns fight stress at brain gym
7:46am EDT
U.S. Morning Call: News Corp mulls splitting into two: WSJ
Mon, Jun 25 2012
Pictures
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Battleground Arizona
A look at the fight over Arizona's controversial immigration law. Slideshow
Best of Euro 2012
Highlights from all the Euro 2012 action. Slideshow
Promoting health? It's all in the game
Tweet
Share this
Email
Print
Related Topics
Science »
Health »
Tech »
Media »
1 of 3. A screenshot showing the character Roxxi in the digital game Re-Mission is seen in this handout image provided to Reuters by the game's producer HopeLab. Gamification - turning boring, unpleasant but necessary tasks into an online game - is a new way of thinking gaining momentum among drugmakers and health campaigners. Roxxi, a feisty and fully-armed virtual nanobot, is billed as ''medicine's mightiest warrior'', and in Re-Mission she's fighting an epic battle deep inside the human body where she launches rapid-fire assaults on malignant cells.
Credit: Reuters/HopeLab/Handout
By Kate Kelland, Health and Science Correspondent
LONDON |
Tue Jun 26, 2012 7:43am EDT
LONDON (Reuters) - Meet Roxxi - a feisty and fully-armed virtual nanobot. Billed as "medicine's mightiest warrior", she's fighting an epic battle deep inside the human body where she launches rapid-fire assaults on malignant cells.
Or, if it's not cancer but diabetes you're fighting, why not join Britney and Hunter, two digital kids whose adventures to other worlds are spurred on by regular and timely updates of your blood sugar levels.
They are a far cry from chemotherapy, diabetes medications, or aspirin, but Roxxi, Britney and Hunter are some of the buzz products from the brains of those who want to promote health and sell medicines.
Gamification - turning boring, unpleasant but necessary tasks into an online game - is a new way of thinking that is gaining momentum among drugmakers and health campaigners.
It's an idea that seeks to use natural human instincts - playing and learning - to help patients to get to know their illness better and adhere properly to treatment regimens or disease monitoring programs.
"We all grew up learning through play," said Christian Dawson, strategy director at Woolley Pau Gyro, a London-based healthcare advertising agency. "Gamification is a way pharma can use that basic human instinct to get the right information into peoples' heads."
FINDING FUN FOR SICK CHILDREN
For 10-year-old Eleanor Howarth being able to play while trying to deal with the shock of being diagnosed with juvenile diabetes, was literally a game changer.
The British schoolgirl was seven and a half when she was told she had the lifelong condition and, as a result, would need to prick and squeeze blood out of her own finger four times a day to check and register her blood glucose levels.
Faced with blank refusals from a terrified child, Eleanor's parents got hold of the "Didget" monitor made by German drugmaker Bayer .
It comes with a game called "Knock 'Em Downs" and can be plugged into a Nintendo DS - the games console beloved of millions of children - and rewards the patient/player for regular blood updates by adding points and new features.
"It turned something she was really quite fearful about into something that could be a bit of fun," said Eleanor's father Richard Howarth. Her mother Donna said "it changed her whole perspective on the diabetes."
Didget took its inspiration, in part, from Re-Mission, widely cited as one of the first successful health games.
Developed in 2006 by HopeLab, a non-profit U.S. organization focused on children's health, and featuring the tumor-fighting Roxxi, it is designed to give patients a sense of power and control over the disease and help them understand why they must have certain treatments and what those treatments will do.
But games are not just for kids.
CAN DIGITAL GAMES BE HEALTHY?
A recent report by analysts at Ernst and Young on trends in the global life science sector noted the rise of gamification in health and hailed its great potential.
"We enjoy playing games - they motivate us and give us feelings of accomplishment, purpose and social connectivity," the report said.
In a chapter dedicated to gamification, J. Leighton Read, a U.S. expert on health games argued that "at a time when health care is focused on outcomes and seeking sustainability, the case for gamification has never been stronger."
But can Big Pharma, traditionally so conservative and hampered by stricter marketing regulations than many other sectors, really win from this game?
Bayer, one of the early enthusiasts, now has some doubts. A spokeswoman for the German firm said it was no longer promoting the Didget monitor because of concerns about whether encouraging children to stay indoors playing computer games was the right health message to send out.
Since gamification is relatively new in health care, and even newer in the pharma sector, follow-up studies on its effects are sparse.
But research published in the journal Pediatrics found that children who played Re-Mission showed improved behavioral and psychological factors linked with successful cancer treatment.
Kieran Walsh, clinical director of BMJ Learning, an education division of the British Medical Journal group, says he's "not an enormous fan" of the term gamification because he fears it can sometimes trivialize medical education.
He prefers the term simulation which, in his field, uses many of the same ideas as gamification.
LEARNER CENTRED
Walsh sees the main use, and benefit, of games in this sector emerging from simulations that help doctors and other health professionals learn new skills, or keep up to date with the latest diagnostic guidelines or treatment protocols.
"Simulation is currently transforming medical education," he said. "It allows doctors to enhance and practice their skills as often as they like, unlike traditional learning which is often done via medical conferences where the learner is more passive and training is dependent on knowledge transfer."
"Modern medical education is becoming far more learner-centered, putting learners at the core and making them actively participate. One way of doing that is simulation."
Indeed major drugmakers, GlaxoSmithKline and Pfizer among them, have reported success with campaigns centered around gamification designed first to attract, and then teach, doctors and other health workers.
GSK won a marketing award for an online game called "Paper to Patient" designed to help doctors learn about important but rather tiresome policy changes on how to manage patients with an illness called chronic obstructive pulmonary disease.
And a Pfizer game called "Back in Play" - designed to help players spot early signs of a progressive form of arthritis called enclosing spondylitis - won an award for public education.
RUN YOUR OWN DRUG COMPANY
John Pugh is director of digital communications at the privately-held German drugmaker Boehringer Ingelheim and one of the market leaders in this field with games like HealthSeeker, a game to help patients learn more about diabetes.
He says it's early days, but sees great health potential in playing games - even if they are the online sort.
Pugh says gamification works for Boehringer on several levels - first as a way to better engage with patients who take the firm's medicines, second as a way to awareness about particular diseases in a wider population, and thirdly as way of boosting the reputation of the pharma industry.
That third ambition has inspired his most recent adventure into the gaming world - a game on the social networking platform Facebook all about how to run a pharmaceutical firm.
Called Syrum, the game puts the player in the shoes of a drug company executive trying to negotiate the minefield of how to discover and developing new medicines, decide which ones to pursue and fund through expensive and time-consuming clinical trials, and what to do about securing patents to secure profits.
"This industry often struggles to have a dialogue or an emotional link with people," Pugh told Reuters.
"So for us, it's natural to apply gamification, which taps into a fundamental of human nature - playing and making learning fun - to health care."
(Editing by Anna Willard)
Science
Health
Tech
Media
Related Quotes and News
Company
Price
Related News
Tweet this
Link this
Share this
Digg this
Email
Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Back to top
Reuters.com
Business
Markets
World
Politics
Technology
Opinion
Money
Pictures
Videos
Site Index
Legal
Bankruptcy Law
California Legal
New York Legal
Securities Law
Support & Contact
Support
Corrections
Connect with Reuters
Twitter
Facebook
LinkedIn
RSS
Podcast
Newsletters
Mobile
About
Privacy Policy
Terms of Use
AdChoices
Copyright
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
Thomsonreuters.com
About Thomson Reuters
Investor Relations
Careers
Contact Us
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.